Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.4 GBX | -2.34% | +1.13% | +1.62% |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Sales 2022 | 18.69M 23.34M | Sales 2023 | -39.79M -49.69M | Capitalization | 992M 1.24B |
---|---|---|---|---|---|
Net income 2022 | 8M 9.99M | Net income 2023 | -56M -69.93M | EV / Sales 2022 | 57.1 x |
Net cash position 2022 | 276K 345K | Net cash position 2023 | 11K 13.74K | EV / Sales 2023 | -24.9 x |
P/E ratio 2022 |
122
x | P/E ratio 2023 |
-17.7
x | Employees | 1,208 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.81% |
Latest transcript on Syncona Limited
1 day | -2.34% | ||
1 week | +1.13% | ||
Current month | +1.95% | ||
1 month | +1.95% | ||
3 months | +6.81% | ||
6 months | -0.48% | ||
Current year | +1.62% |
Managers | Title | Age | Since |
---|---|---|---|
Annabel Clark
IRC | Investor Relations Contact | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 22-01-31 | |
Virginia Holmes
BRD | Director/Board Member | 64 | 20-12-31 |
Kemal Malik
BRD | Director/Board Member | 61 | 20-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 125.4 | -2.34% | 435,805 |
24-04-29 | 128.4 | -.--% | 776,277 |
24-04-26 | 128.4 | +1.10% | 791,286 |
24-04-25 | 127 | +0.79% | 217,073 |
24-04-24 | 126 | +1.61% | 1,152,173 |
Delayed Quote London S.E., April 30, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.62% | 1.05B | |
+16.98% | 76.16B | |
+59.45% | 17.61B | |
+2.74% | 15.94B | |
+8.60% | 14.05B | |
-0.04% | 12.4B | |
+8.96% | 12.06B | |
+5.82% | 10.89B | |
+34.35% | 10.34B | |
-1.92% | 9.75B |
- Stock Market
- Equities
- BACT Stock